Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Interesting

<< Previous

Bullboard Posts

Next >>

Comment by juniper88on Jul 25, 2021 12:34am

113 Views

Post# 33601613

RE:Interesting

I believe it is a pretty standard premed for chemo, in particular for taxol or Carboplatin. My wife has to take two of the hexagon shaped tablets 1 hour before chemo, then 2 more the next day, and 2 more the day after that. She done this for all of her 18 cycles so far. The oncologist told us it is to avoid an allergic reaction from the chemo.

scarlet1967 wrote:

I didn’t know they use Dexamethasone and TH1902 in the trial. As per Karmanos cancer Center that’s the case!

Use in Cancer

Dexamethasone is approved to be used to reduce inflammation and suppress (lower) the body's immune response. Dexamethasone is used with other drugs to treat the following types of cancer: Leukemia. Lymphoma.

Find a Karmanos Clinical Trial

THERAPIES

Biological Therapy

DRUGS

Dexamethasone; TH1902